Sprint Bioscience AB Financial Overview
Sprint Bioscience AB's market cap is currently €13.90M. The company's EPS TTM is €-0.007312; its P/E ratio is -4.07; Sprint Bioscience AB is scheduled to report earnings on November 25, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
